{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:38:11Z","timestamp":1772836691440,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003098","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:05:47Z","timestamp":1461330347000},"page":"e3098","source":"Crossref","is-referenced-by-count":28,"title":["Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma"],"prefix":"10.1097","volume":"95","author":[{"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-56-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-56-20210226","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"R3-56-20210226","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.canlet.2014.01.004","article-title":"Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China","volume":"346","author":"Long","year":"2014","journal-title":"Cancer Lett"},{"key":"R4-56-20210226","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-11-2994","article-title":"Metformin use is associated with better survival of diabetic patients with pancreatic cancer","volume":"18","author":"Sadeghi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R5-56-20210226","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-56-20210226","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamasurg.2015.0668","article-title":"Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma","volume":"150","author":"Paniccia","year":"2015","journal-title":"JAMA Surg"},{"key":"R7-56-20210226","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/MD.0000000000000751","article-title":"Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine"},{"key":"R8-56-20210226","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2006.09.2551","article-title":"Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer","volume":"25","author":"Sultana","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-56-20210226","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-56-20210226","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","article-title":"nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discov"},{"key":"R11-56-20210226","doi-asserted-by":"crossref","first-page":"e40847","DOI":"10.1371\/journal.pone.0040847","article-title":"Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"R12-56-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2011.11.029","article-title":"Combinational therapy: new hope for pancreatic cancer?","volume":"317","author":"Shi","year":"2012","journal-title":"Cancer Lett"},{"key":"R13-56-20210226","first-page":"338","article-title":"A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer","volume":"43","author":"Ohigashi","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"R14-56-20210226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1008335331516","article-title":"Intra-arterial chemotherapy for unresectable pancreatic cancer","volume":"11","author":"Cantore","year":"2000","journal-title":"Ann Oncol"},{"key":"R15-56-20210226","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2214\/AJR.11.8008","article-title":"Unresectable pancreatic cancer: arterial embolization to achieve a single blood supply for intraarterial infusion of 5-fluorouracil and full-dose IV gemcitabine","volume":"198","author":"Tanaka","year":"2012","journal-title":"Am J Roentgenol"},{"key":"R17-56-20210226","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jcp.37.2.218","article-title":"Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases","volume":"37","author":"Jalanko","year":"1984","journal-title":"J Clin Pathol"},{"key":"R18-56-20210226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0169-2607(97)00043-6","article-title":"Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions","volume":"54","author":"Heinzl","year":"1997","journal-title":"Comput Methods Programs Biomed"},{"key":"R19-56-20210226","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"R20-56-20210226","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","article-title":"New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer","volume":"12","author":"Hong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R21-56-20210226","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N Engl J Med"},{"key":"R22-56-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03207753","article-title":"The arterial blood supply of the pancreas: a review","volume":"18","author":"Bertelli","year":"1996","journal-title":"Surg Radiol Anat"},{"key":"R23-56-20210226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.mpa.0000158025.46172.ae","article-title":"5-Fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer","volume":"30","author":"Takamori","year":"2005","journal-title":"Pancreas"},{"key":"R24-56-20210226","first-page":"751","article-title":"Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience","volume":"20","author":"Mambrini","year":"2006","journal-title":"In Vivo"},{"key":"R25-56-20210226","first-page":"346","article-title":"Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer","volume":"43","author":"Muchmore","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"R26-56-20210226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9610(06)80068-1","article-title":"Isolated perfusion of pancreas with mitomycin C","volume":"159","author":"Arredondo","year":"1990","journal-title":"Am J Surg"},{"key":"R27-56-20210226","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/pmic.201100676","article-title":"Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation","volume":"12","author":"Partyka","year":"2012","journal-title":"Proteomics"},{"key":"R28-56-20210226","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/archsurg.138.9.951","article-title":"Utility of tumor markers in determining resectability of pancreatic cancer","volume":"138","author":"Schlieman","year":"2003","journal-title":"Arch Surg"},{"key":"R29-56-20210226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12094-012-0770-x","article-title":"Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma","volume":"14","author":"Zhang","year":"2012","journal-title":"Clin Translat Oncol"},{"key":"R30-56-20210226","first-page":"835","article-title":"CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy","volume":"23","author":"Micke","year":"2003","journal-title":"Anticancer Res"},{"key":"R31-56-20210226","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/bjc.1998.50","article-title":"Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?","volume":"77","author":"Gogas","year":"1998","journal-title":"Br J Cancer"},{"key":"R32-56-20210226","first-page":"2433","article-title":"CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin","volume":"19","author":"Heinemann","year":"1999","journal-title":"Anticancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:39:36Z","timestamp":1718491176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003098","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}